Category: ORTHOPEDICS

Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch

September 10, 2026

GRAND RAPIDS, Mich., Sept. 10, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (“Shoulder Innovations”, or “the company”) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the N-22 Humeral Head, a titanium implant option for patients with metal hypersensitivity. Alongside the clearance, the company also announced the product’s full commercial launch.

Soft back belts ease everyday low back pain, 12-week trial suggests

September 8, 2026

For many in the workforce, spending hours at a computer is an unavoidable part of daily life. Sitting for prolonged periods in the same position can contribute to low back pain (LBP), which affects up to 80% of people over their lifetime and remains a leading cause of disability worldwide. A group of French researchers decided to find out whether wearing a soft, flexible lower-back support belt can help people with common, unexplained lower back pain feel better and move more easily.

Newly discovered stem cell reveals potential drug target for spinal stenosis

September 7, 2026

Researchers at Weill Cornell Medicine and Hospital for Special Surgery have discovered the unspecialized stem cells that give rise to the body’s tendons and ligaments, the tissues connecting muscles and bones.

Globus Medical wins CE mark for Excelsius3D imaging system

September 4, 2026

Globus Medical (NYSE: GMED) has secured a CE mark for its Excelsius3D intelligent 3-in-1 imaging system for spine and cranial procedures.

FibroBiologics Announces Issuance of New U.S. Patent for the Treatment of Degenerative Disc Disease Using Fibroblast Conditioned Media

September 1, 2026

Newly Issued Patent Covers Methods of Promoting Disc Regeneration Using Components Derived from Stimulated Fibroblasts

Mimicking natural connections could improve rotator cuff repair

August 26, 2026

Researchers have developed a “scaffold” that mimics natural tissue and could lead to more durable rotator cuff repairs, including for large injuries and cases involving bone and tissue degeneration that are often the most difficult to fix. Devised by a team at the Perelman School of Medicine at the University of Pennsylvania, the new system was detailed in Science Advances.

FibroBiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair in Preclinical Study of Degenerative Joints

August 18, 2026

Animal trials show cartilage repair within four weeks following a single injection of chondrocyte spheroids

Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™

August 14, 2026

BALTIMORE, Aug. 14, 2026 /PRNewswire/ — Nanochon, a medical device company developing Chondrograft™, a novel patented implant for the treatment of articular cartilage defects of the knee, today announced that it has received regulatory approval from Panamá’s Ministry of Health to initiate its First-in-Human (FIH) clinical study in Panamá.

Spineart Announces FDA Approval of BAGUERA® C Cervical Disc

August 11, 2026

GENEVA, Aug. 11, 2026 /PRNewswire/ — Spineart announces that the BAGUERA® C cervical disc has received FDA approval for 1 and 2 contiguous levels, expanding access in the United States to a motion-preserving solution for patients suffering from cervical disc disease.

New mechanism reveals how heart cells resist regenerative reprogramming

July 29, 2026

Specialized cells in the human body make biological trade-offs to perform certain jobs. Because the adult human heart cannot repair itself the way skin does, scientists have studied ways to “reprogram” heart cells to regenerate after heart attacks.

Blog

- ORTHOPEDICS